PubMed:27184800 / 1523-1692 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T13","span":{"begin":0,"end":169},"obj":"Sentence"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin-entities","denotations":[{"id":"11357","span":{"begin":46,"end":49},"obj":"GeneOrGeneProduct"},{"id":"11358","span":{"begin":80,"end":83},"obj":"DiseaseOrPhenotypicFeature"},{"id":"11359","span":{"begin":84,"end":92},"obj":"OrganismTaxon"},{"id":"11360","span":{"begin":103,"end":112},"obj":"ChemicalEntity"}],"attributes":[{"id":"A34","pred":"db_id","subj":"11357","obj":"NCBIGene:4495"},{"id":"A35","pred":"db_id","subj":"11358","obj":"MESH:D006528"},{"id":"A36","pred":"db_id","subj":"11359","obj":"NCBITaxon:9606"},{"id":"A37","pred":"db_id","subj":"11360","obj":"MESH:D000077157"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T39","span":{"begin":28,"end":35},"obj":"GeneOrGeneProduct"},{"id":"T40","span":{"begin":46,"end":49},"obj":"GeneOrGeneProduct"},{"id":"T41","span":{"begin":144,"end":151},"obj":"GeneOrGeneProduct"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T23","span":{"begin":28,"end":35},"obj":"GeneOrGeneProduct"},{"id":"T24","span":{"begin":46,"end":49},"obj":"GeneOrGeneProduct"},{"id":"T25","span":{"begin":144,"end":151},"obj":"GeneOrGeneProduct"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T19","span":{"begin":80,"end":83},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A19","pred":"originalLabel","subj":"T19","obj":"DISEASE"},{"id":"A20","pred":"originalLabel","subj":"T19","obj":"D006528"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T12","span":{"begin":46,"end":49},"obj":"GeneOrGeneProduct"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T7","span":{"begin":80,"end":83},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"0007256"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T19","span":{"begin":80,"end":83},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A19","pred":"ID:","subj":"T19","obj":"DISEASE"},{"id":"A20","pred":"ID:","subj":"T19","obj":"D006528"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T18","span":{"begin":80,"end":83},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A18","pred":"#label","subj":"T18","obj":"DISEASE"},{"id":"A19","pred":"#label","subj":"T18","obj":"D006528"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T4","span":{"begin":84,"end":92},"obj":"OrganismTaxon"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T20","span":{"begin":103,"end":112},"obj":"ChemicalEntity"}],"attributes":[{"id":"A20","pred":"ID:","subj":"T20","obj":"D000077157"},{"id":"A21","pred":"ID:","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}

{"project":"LitCoin-training-merged","denotations":[{"id":"T20","span":{"begin":103,"end":112},"obj":"ChemicalEntity"},{"id":"T66692","span":{"begin":46,"end":49},"obj":"GeneOrGeneProduct"},{"id":"T18","span":{"begin":80,"end":83},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T40254","span":{"begin":84,"end":92},"obj":"OrganismTaxon"}],"attributes":[{"id":"A21","pred":"ID:","subj":"T20","obj":"http://purl.obolibrary.org/obo/CHEBI_50924"},{"id":"A20","pred":"ID:","subj":"T20","obj":"D000077157"},{"id":"A50535","pred":"#label","subj":"T18","obj":"D006528"},{"id":"A63097","pred":"#label","subj":"T18","obj":"DISEASE"}],"text":"Finally, we showed that the protein levels of MT1 increase in the serum of some HCC patients receiving sorafenib, and found an association with reduced overall survival."}